Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: J Am Coll Surg. 2011 Aug 25;213(5):596–603.e1. doi: 10.1016/j.jamcollsurg.2011.07.015

Figure 1.

Figure 1

Trend of (A) venous thromboembolism (VTE) pharmacologic prophylaxis use and (B) 90-d composite adverse events (CAE) over time.